Marjolein Geurts
16PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Mar 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.Rosa Luning, Sybren L N Maas, Pim J French
|Mar 09, 2026
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumors.Nelleke Tolboom, Antoine Verger, Matthias Preusser
|Jul 28, 2025
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas.Sebastien Perreault, Marjolein Geurts, Jasia Mahdi
|Apr 30, 2025
Correlative studies in central nervous system tumors clinical trials: The emerging role of microbiome research.Raoull Hoogendijk, Marjolein Geurts, Jasper van der Lugt
|Mar 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig
|Jan 08, 2025
Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations.Katherine B Peters, Marjolein Geurts
Pageof 3
Frequent Collaborators
5 joint publications
Martin J van den Bent
5 joint publications
Matthias Preusser
3 joint publications
Pim J French
3 joint publications
Michael Weller
2 joint publications
Pierre A Robe
1 joint publications
Tom J Snijders
1 joint publications
Jan C Buckner
1 joint publications
Derek R Johnson
1 joint publications
Levi van Hijfte
1 joint publications
Aline Paixao Becker
